Your browser doesn't support javascript.
loading
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.
Sutton, Henry J; Aye, Racheal; Idris, Azza H; Vistein, Rachel; Nduati, Eunice; Kai, Oscar; Mwacharo, Jedida; Li, Xi; Gao, Xin; Andrews, T Daniel; Koutsakos, Marios; Nguyen, Thi H O; Nekrasov, Maxim; Milburn, Peter; Eltahla, Auda; Berry, Andrea A; Kc, Natasha; Chakravarty, Sumana; Sim, B Kim Lee; Wheatley, Adam K; Kent, Stephen J; Hoffman, Stephen L; Lyke, Kirsten E; Bejon, Philip; Luciani, Fabio; Kedzierska, Katherine; Seder, Robert A; Ndungu, Francis M; Cockburn, Ian A.
  • Sutton HJ; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Aye R; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia; KEMRI - Wellcome Research Programme/Centre for Geographical Medicine Research (Coast), Kilifi, Kenya.
  • Idris AH; Vaccine Research Center, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA.
  • Vistein R; Vaccine Research Center, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA.
  • Nduati E; KEMRI - Wellcome Research Programme/Centre for Geographical Medicine Research (Coast), Kilifi, Kenya; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
  • Kai O; KEMRI - Wellcome Research Programme/Centre for Geographical Medicine Research (Coast), Kilifi, Kenya.
  • Mwacharo J; KEMRI - Wellcome Research Programme/Centre for Geographical Medicine Research (Coast), Kilifi, Kenya.
  • Li X; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Gao X; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Andrews TD; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Koutsakos M; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, VIC 3000, Australia.
  • Nguyen THO; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, VIC 3000, Australia.
  • Nekrasov M; Australian Cancer Research Foundation Biomolecular Resource Facility, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Milburn P; Australian Cancer Research Foundation Biomolecular Resource Facility, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
  • Eltahla A; School of Medical Science, Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
  • Berry AA; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Kc N; Sanaria Inc., Rockville, MD 20850, USA.
  • Chakravarty S; Sanaria Inc., Rockville, MD 20850, USA.
  • Sim BKL; Sanaria Inc., Rockville, MD 20850, USA.
  • Wheatley AK; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, VIC 3000, Australia; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia.
  • Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, VIC 3000, Australia; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, VIC, Australia.
  • Hoffman SL; Sanaria Inc., Rockville, MD 20850, USA.
  • Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Bejon P; KEMRI - Wellcome Research Programme/Centre for Geographical Medicine Research (Coast), Kilifi, Kenya; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
  • Luciani F; School of Medical Science, Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
  • Kedzierska K; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, VIC 3000, Australia.
  • Seder RA; Vaccine Research Center, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA.
  • Ndungu FM; KEMRI - Wellcome Research Programme/Centre for Geographical Medicine Research (Coast), Kilifi, Kenya; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
  • Cockburn IA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia. Electronic address: ian.cockburn@anu.edu.au.
Cell Rep ; 34(6): 108684, 2021 02 09.
Article en En | MEDLINE | ID: mdl-33567273
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium / Anticuerpos Antiprotozoarios / Linfocitos B / Vacunación / Vacunas contra la Malaria / Malaria Tipo de estudio: Clinical_trials Límite: Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium / Anticuerpos Antiprotozoarios / Linfocitos B / Vacunación / Vacunas contra la Malaria / Malaria Tipo de estudio: Clinical_trials Límite: Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article